Can Thyroidectomy be Considered Safe in Obese Patients?

Can Thyroidectomy be Considered Safe in Obese Patients? Retrospective Cohort Study

Obesity is a growing public health concern in most western countries. More and more patients with high body mass index (BMI) are undergoing surgical procedures of all kinds and, in this context, obese patients are undergoing thyroid surgery more than ever before. This study showed that obesity, in the field of thyroid surgery, is not associated with any increase of postoperative complications. Thus, it is possible to conclude that thyroidectomy can be performed safely in obese patients.

Study Overview

• Status: Completed
• Conditions: Obesity; Surgery--Complications; Thyroid

Detailed Description

Background: Obesity is a growing public health concern in most western countries. More and more patients with high body mass index (BMI) are undergoing surgical procedures of all kinds and, in this context, obese patients are undergoing thyroid surgery more than ever before. The aim of the present study was to evaluate whether thyroidectomy can be considered safe in obese patients.

Methods: Patients undergoing thyroidectomy in our Unit between January 2014 and December 2018 were retrospectively analysed. Patients were divided into 2 groups: those with BMI < 30 kg/m2 were included in Group A, while those with BMI ≥ 30 kg/m2 in Group B.

• Study Type: Observational
• Enrollment (Actual): 813

Contacts and Locations

Study Locations

• Italy
  • CA
    • Monserrato, CA, Italy, 09042
      • Policlinico di Monserrato

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child; Adult; Older Adult
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

Patients submitted to thyroidectomy

Description

Inclusion Criteria:

• Patients submitted to thyroidectomy in our Unit

Exclusion Criteria:

-

Study Plan

How is the study designed?

Number of groups / cohorts

2

Cohorts and Interventions

Group / Cohort
Obese patients
Non-obese patients

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Postoperative complications	Occurrence of postoperative complications	1 year

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Operative time	Evaluation of operatives times	1 day

Other Outcome Measures

Outcome Measure	Measure Description	Time Frame
Postoperative stay	Evaluation of postoperative stay	up to 2 weeks

Collaborators and Investigators

• Sponsor: University of Cagliari
• Investigators: Study Director: Pietro Giorgio Calò, University of Cagliari

Study record dates

Study Major Dates

• Study Start (Actual): December 1, 2019
• Primary Completion (Actual): January 1, 2020
• Study Completion (Actual): February 1, 2020

Study Registration Dates

• First Submitted: February 13, 2020
• First Submitted That Met QC Criteria: February 14, 2020
• First Posted (Actual): February 18, 2020

Study Record Updates

• Last Update Posted (Actual): February 18, 2020
• Last Update Submitted That Met QC Criteria: February 14, 2020
• Last Verified: February 1, 2020

More Information

Terms related to this study

• Other Study ID Numbers: NP20193369

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No